Astrazeneca Share Discussion Threads

[jimarilo] 06/5/2021 15:01

To the covid satanic death cult

[riskonricky] 05/5/2021 17:05

Even my nanna knows that a tiny bit of spike protein in her arm might hurt a muscle cell - but at least it's not in her lungs and at least it's not alive to make more! It makes me sick that you would spread this nonsense. What a complete loser.

[stutes] 05/5/2021 15:28

Why buy Alexion- why not create a jv to bankroll Alexion's pipeline?

[stutes] 05/5/2021 15:04

I have seen how the share AZN price reacted to Alexion deal and I will vote against the deal. I will not reward the City or speculators by voting the deal through.

[gregb] 05/5/2021 09:39

Think you need to read the terms of the deal :-)

[philanderer] 05/5/2021 09:34

‘Obscene’ bonus hike for AstraZeneca boss prompts investor anger

Advisory groups ask shareholders to oppose bid to raise Pascal Soriot’s maximum share bonus to 650% of £1.3m basic pay

[montyhedge] 05/5/2021 07:17

Good old Astra for free, fair play to them.

[philanderer] 05/5/2021 01:15

Pfizer predicts sales of nearly £19bn from its Covid vaccine in 2021 as world recovers from the pandemic

[stutes] 04/5/2021 10:36

I note how Alexion adr is around $170 level - below bid price. I don't buy into the recent increase while AZN share price remains below £85 to £100 range. Alexion needs AZN's cash to fund future r&d - time to renegotiate the bid price ?

[jimarilo] 04/5/2021 07:04

@ bill gates

[smcni1968] 30/4/2021 20:43

Unhelpfully 1 UK listed share = 2 US shares

[freddie ferret] 30/4/2021 18:47

I hope Monty's shorts are not on fire!

[philanderer] 30/4/2021 16:23

Downtrend looks to have reversed.

[imastu pidgitaswell] 30/4/2021 15:19

$5 is how many Pounds? Compare with the share price...

[imastu pidgitaswell] 30/4/2021 15:19

Nope. Try again...

[beckers2008] 30/4/2021 15:16

E,

AZN reports in $. 53/4.75 = 11ish.
Not much resistance to hit £80.

[hotfinance14] 30/4/2021 14:43

Heading towards an share price of £80.

[poikka] 30/4/2021 13:35

This is a start.

"The chief executive of AstraZeneca has hit back at critics in Brussels over jab shortages and said India would have had "no vaccines" without it.

Pascal Soriot, speaking at its first quarter results on Friday, said the company had "done its best" on delivering vaccines for the Covid pandemic, even in the face of intense criticism.

He said at the start of the pandemic "everybody was talking about 120, 130 vaccines in development - we forget that. But where are all those vaccines? They're nowhere."

"Without AstraZeneca, there would be no vaccine in India and no supply to Covax", Mr Soriot said, referring to the organisation delivering jabs to developing countries.

Mr Soriot is expected to return to Britain next month, having travelled to Australia around Christmas to be with his family.

"My life has been spent around 80pc on video over the past couple of years, because I manage a global network and have a team based in Sweden, Cambridge, the US, China," he said.

"We've learned to work remotely, even more so, which by the way helps us to reduce our carbon footprint, so working digitally is certainly something we'll do even more in the future."

AstraZeneca provided figures that showed it had delivered 90pc of the vaccines in India, which has been gripped by a deadly wave of the virus in recent weeks, and 98pc of the vaccines to Covax."

[essentialinvestor] 30/4/2021 11:59

Those numbers need to be converted to GBP ?, I dont think the PE is 11x.

Last time I got around 16.5x on (current) FY 2023 estimates.

Estimates will change significantly on completion of the Alexion deal.

[beckers2008] 30/4/2021 11:33

FY guidance of $4.75/$5 per share gives a forward PE of around 11 at current share price of $53.
Can't see AZN being as low as $53 in 10 months time and should have an impact here?

[essentialinvestor] 30/4/2021 09:32

Lovely, sold a few.

[montyhedge] 30/4/2021 09:31

Much better than expect, well done bulls.

[rettah] 30/4/2021 08:45

"We expect the impact of COVID to reduce and anticipate a performance acceleration in the second half of 2021." Nice.

When you look at the new drugs, forward pipeline and recent approvals (e.g. Tagrisso in china) then this looks a great company to hold.